| 治疗耐甲氧西林金黄色葡萄球菌感染的抗体药物 |
| |
| 引用本文： | 顾江,邹全明.治疗耐甲氧西林金黄色葡萄球菌感染的抗体药物[J].中国生物工程杂志,2012,32(2):96-99. |
| |
| 作者姓名： | 顾江 邹全明 |
| |
| 作者单位： | 第三军医大学药学院 重庆 400038 |
| |
| 基金项目： | 重庆市自然科学基金资助项目(CSTC2011jjA10071) |
| |
| 摘 要： | 耐甲氧西林金黄色葡萄球菌(methicillin-resistant staphylococcus aureus, MRSA) 作为超级细菌的典型代表,严重威胁人民群众的健康。目前经典的抗生素治疗和疫苗主动预防都无法有效控制MRSA的感染。近年来,随着抗体药物产业的兴起,诸多药物研发公司和研究人员致力于研究治疗性抗体,以期控制MRSA的感染并已经取得了很多突破。就治疗MRSA感染的抗体药物研究进展作一简要综述。
|
| 关 键 词： | 临床研究 耐甲氧西林金黄色葡萄球菌 抗体药物 |
| 收稿时间： | 2011-11-24 |
| 修稿时间： | 2011-12-23 |
Therapeutic Antibody Drugs on the Control of Methicillin-resistant Staphylococcus aureus |
| |
| GU Jiang
,
ZOU Quan-ming.Therapeutic Antibody Drugs on the Control of Methicillin-resistant Staphylococcus aureus[J].China Biotechnology,2012,32(2):96-99. |
| |
| Authors: | GU Jiang ZOU Quan-ming |
| |
| Institution: | (College of Pharmacy,Third Military Medical University,Chongqing 400038,China) |
| |
| Abstract: | Methicillin-resistant Staphylococcus aureus(MRSA),is a typical member of superbugs and a serious threat to people’s health.However current antibiotics and the active vaccination can not control immunization of MRSA infection effectively.In recent years,with the rapid development of antibody-drug industry,many drug RD companies and researchers working on therapeutic antibodies begin to focus on the development of new antibody drug to control of MRSA infection.The progress and current status of therapeutic antibodies against MRSA were discussed. |
| |
| Keywords: | Methicillin-resistant Staphylococcus aureus Therapeutic antibody Clinical trail |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
| 点击此处可从《中国生物工程杂志》浏览原始摘要信息 |
| 点击此处可从《中国生物工程杂志》下载免费的PDF全文 |
